- Home
- RCKT vs MATV Comparison
RCKT vs MATV Comparison
Compare RCKT & MATV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- MATV
- Stock Information
- Founded
- RCKT 1999
- MATV 1995
- Country
- RCKT United States
- MATV United States
- Employees
- RCKT N/A
- MATV N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- MATV Paper
- Sector
- RCKT Health Care
- MATV Basic Materials
- Exchange
- RCKT Nasdaq
- MATV Nasdaq
- Market Cap
- RCKT 326.4M
- MATV 361.1M
- IPO Year
- RCKT N/A
- MATV 1995
- Fundamental
- Price
- RCKT $2.48
- MATV $6.81
- Analyst Decision
- RCKT Buy
- MATV Strong Buy
- Analyst Count
- RCKT 13
- MATV 1
- Target Price
- RCKT $18.50
- MATV $10.00
- AVG Volume (30 Days)
- RCKT 4.7M
- MATV 623.4K
- Earning Date
- RCKT 08-04-2025
- MATV 08-06-2025
- Dividend Yield
- RCKT N/A
- MATV 5.73%
- EPS Growth
- RCKT N/A
- MATV N/A
- EPS
- RCKT N/A
- MATV N/A
- Revenue
- RCKT N/A
- MATV $1,965,700,000.00
- Revenue This Year
- RCKT N/A
- MATV $3.07
- Revenue Next Year
- RCKT N/A
- MATV $2.30
- P/E Ratio
- RCKT N/A
- MATV N/A
- Revenue Growth
- RCKT N/A
- MATV N/A
- 52 Week Low
- RCKT $2.19
- MATV $4.34
- 52 Week High
- RCKT $26.98
- MATV $19.96
- Technical
- Relative Strength Index (RSI)
- RCKT 31.96
- MATV 59.01
- Support Level
- RCKT $2.50
- MATV $6.36
- Resistance Level
- RCKT $2.70
- MATV $6.77
- Average True Range (ATR)
- RCKT 0.20
- MATV 0.32
- MACD
- RCKT 0.11
- MATV -0.02
- Stochastic Oscillator
- RCKT 4.82
- MATV 60.42
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About MATV Mativ Holdings Inc.
Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.